Literature DB >> 29172794

Mortality in patients with atrial fibrillation and common co-morbidities - a cohort study in primary care.

Per Wändell1, Axel C Carlsson1,2, Martin J Holzmann3,4, Johan Ärnlöv1,5, Jan Sundquist6,7, Kristina Sundquist6,7.   

Abstract

OBJECTIVE: To study the association between cardiovascular co-morbidities and mortality risk in primary care patients with atrial fibrillation.
METHODS: The study population included all adults (n = 12,283) ≥ 45 years diagnosed with AF at 75 primary care centres in Sweden between 2001 and 2007. The outcome was mortality (until 2010) and data were explored for co-morbidities using Cox regression with hazard ratios (HRs). Analyses were performed stratified by sex and by age-group (45-64, 65-74 and ≥75 years of age) with adjustment for age, socio-economic factors and relevant co-morbidities.
RESULTS: During a mean of 5.8 years (standard deviation 2.4) of follow-up, 3954 (32%) patients died (1971 (35%) women, and 1983 (30%) men). High HRs were found for congestive heart disease (CHF) and cerebrovascular diseases for all age-groups among men and women (except for the 45-64 year old women); for coronary heart disease among the oldest men; for diabetes among the 65-74 year old men and the 45-64 year old women. Low HRs were found for hypertension among women ≥75 years of age.
CONCLUSIONS: In this clinical setting, CHF and cerebrovascular diseases were consistently associated with mortality in all age-groups. The possible protective effect by hypertension among elderly women should be interpreted with caution. KEY MESSAGES We found congestive heart failure and cerebrovascular diseases to be consistently associated with mortality in both women and men. We found hypertension to be associated with lower mortality risk among women ≥75 years of age, although this finding must be interpreted with caution. Depression was found to be associated with increased mortality risk among men and women aged 65-74 years of age.

Entities:  

Keywords:  Coronary heart disease; cerebrovascular disease; congestive heart failure; depression; diabetes; gender; hypertension

Mesh:

Year:  2017        PMID: 29172794      PMCID: PMC6133241          DOI: 10.1080/07853890.2017.1407036

Source DB:  PubMed          Journal:  Ann Med        ISSN: 0785-3890            Impact factor:   4.709


  42 in total

Review 1.  Cardiovascular risk factors and dementia.

Authors:  Howard Fillit; David T Nash; Tatjana Rundek; Andrea Zuckerman
Journal:  Am J Geriatr Pharmacother       Date:  2008-06

Review 2.  Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors.

Authors:  F E Harrell; K L Lee; D B Mark
Journal:  Stat Med       Date:  1996-02-28       Impact factor: 2.373

3.  Psychopathology and symptoms of atrial fibrillation: implications for therapy.

Authors:  Anil K Gehi; Samuel Sears; Neeta Goli; T Jennifer Walker; Eugene Chung; Jennifer Schwartz; Kathryn A Wood; Kimberly Guise; J Paul Mounsey
Journal:  J Cardiovasc Electrophysiol       Date:  2012-03-19

Review 4.  Risk Factors and Genetics of Atrial Fibrillation.

Authors:  Justus M B Anumonwo; Jérôme Kalifa
Journal:  Heart Fail Clin       Date:  2016-04       Impact factor: 3.179

Review 5.  Comprehensive risk reduction in patients with atrial fibrillation: emerging diagnostic and therapeutic options--a report from the 3rd Atrial Fibrillation Competence NETwork/European Heart Rhythm Association consensus conference.

Authors:  Paulus Kirchhof; Gregory Y H Lip; Isabelle C Van Gelder; Jeroen Bax; Elaine Hylek; Stefan Kaab; Ulrich Schotten; Karl Wegscheider; Giuseppe Boriani; Axel Brandes; Michael Ezekowitz; Hans Diener; Laurent Haegeli; Hein Heidbuchel; Deirdre Lane; Luis Mont; Stephan Willems; Paul Dorian; Maria Aunes-Jansson; Carina Blomstrom-Lundqvist; Maria Borentain; Stefanie Breitenstein; Martina Brueckmann; Nilo Cater; Andreas Clemens; Dobromir Dobrev; Sergio Dubner; Nils G Edvardsson; Leif Friberg; Andreas Goette; Michele Gulizia; Robert Hatala; Jenny Horwood; Lukas Szumowski; Lukas Kappenberger; Josef Kautzner; Angelika Leute; Trudie Lobban; Ralf Meyer; Jay Millerhagen; John Morgan; Felix Muenzel; Michael Nabauer; Christoph Baertels; Michael Oeff; Dieter Paar; Juergen Polifka; Ursula Ravens; Ludger Rosin; W Stegink; Gerhard Steinbeck; Panos Vardas; Alphons Vincent; Maureen Walter; Günter Breithardt; A John Camm
Journal:  Europace       Date:  2011-07-26       Impact factor: 5.214

6.  Prevalence of unknown atrial fibrillation in patients with risk factors.

Authors:  Alexander Samol; Markus Masin; Reinhold Gellner; Britta Otte; Hermann-Joseph Pavenstädt; Erich Bernd Ringelstein; Holger Reinecke; Johannes Waltenberger; Paulus Kirchhof
Journal:  Europace       Date:  2012-12-20       Impact factor: 5.214

Review 7.  Psychological distress in patients diagnosed with atrial fibrillation: the state of the science.

Authors:  Pamela J McCabe
Journal:  J Cardiovasc Nurs       Date:  2010 Jan-Feb       Impact factor: 2.083

8.  Effects of prescribed antihypertensives and other cardiovascular drugs on mortality in patients with atrial fibrillation and hypertension: a cohort study from Sweden.

Authors:  Axel C Carlsson; Per Wändell; Kristina Sundquist; Sven-Erik Johansson; Jan Sundquist
Journal:  Hypertens Res       Date:  2014-03-06       Impact factor: 3.872

Review 9.  Atrial fibrillation and the risk for myocardial infarction, all-cause mortality and heart failure: A systematic review and meta-analysis.

Authors:  Vidar Ruddox; Irene Sandven; John Munkhaugen; Julie Skattebu; Thor Edvardsen; Jan Erik Otterstad
Journal:  Eur J Prev Cardiol       Date:  2017-06-15       Impact factor: 7.804

10.  Simple risk model predicts incidence of atrial fibrillation in a racially and geographically diverse population: the CHARGE-AF consortium.

Authors:  Alvaro Alonso; Bouwe P Krijthe; Thor Aspelund; Katherine A Stepas; Michael J Pencina; Carlee B Moser; Moritz F Sinner; Nona Sotoodehnia; João D Fontes; A Cecile J W Janssens; Richard A Kronmal; Jared W Magnani; Jacqueline C Witteman; Alanna M Chamberlain; Steven A Lubitz; Renate B Schnabel; Sunil K Agarwal; David D McManus; Patrick T Ellinor; Martin G Larson; Gregory L Burke; Lenore J Launer; Albert Hofman; Daniel Levy; John S Gottdiener; Stefan Kääb; David Couper; Tamara B Harris; Elsayed Z Soliman; Bruno H C Stricker; Vilmundur Gudnason; Susan R Heckbert; Emelia J Benjamin
Journal:  J Am Heart Assoc       Date:  2013-03-18       Impact factor: 5.501

View more
  8 in total

1.  Association Between Relevant Co-Morbidities and Dementia With Atrial Fibrillation-A National Study.

Authors:  Per Wändell; Axel C Carlsson; Xinjun Li; Jan Sundquist; Kristina Sundquist
Journal:  Arch Med Res       Date:  2019-05-31       Impact factor: 2.235

2.  Associations between relevant cardiovascular pharmacotherapies and incident heart failure in patients with atrial fibrillation: a cohort study in primary care.

Authors:  Per Wändell; Axel C Carlsson; Martin J Holzmann; Johan Ärnlöv; Jan Sundquist; Kristina Sundquist
Journal:  J Hypertens       Date:  2018-09       Impact factor: 4.844

3.  The association between gout and cardiovascular disease in patients with atrial fibrillation.

Authors:  Per Wändell; Axel C Carlsson; Jan Sundquist; Kristina Sundquist
Journal:  SN Compr Clin Med       Date:  2019-01-28

4.  Use of cardiovascular drugs and risk of incident heart failure in patients with atrial fibrillation.

Authors:  Per Wändell; Axel C Carlsson; Xinjun Li; Martin J Holzmann; Jan Sundquist; Kristina Sundquist
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-07-15       Impact factor: 3.738

5.  Effect of Levothyroxine Treatment on Incident Dementia in Adults with Atrial Fibrillation and Hypothyroidism.

Authors:  Per Wändell; Axel C Carlsson; Jan Sundquist; Kristina Sundquist
Journal:  Clin Drug Investig       Date:  2019-02       Impact factor: 2.859

6.  Impact of preexisting diabetes mellitus on cardiovascular and all-cause mortality in patients with atrial fibrillation: A meta-analysis.

Authors:  Juan Xu; Yimeng Sun; Dandan Gong; Yu Fan
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-01       Impact factor: 6.055

7.  The unmeasured burden: Contribution of depression and psychological stress to patient-reported outcomes in atrial fibrillation.

Authors:  Brittany Gisi; Andrew D Althouse; Abigail S Mathier; Alexandra Pusateri; Bruce L Rollman; Anna LaRosa; Jared W Magnani
Journal:  Int J Cardiol       Date:  2019-12-05       Impact factor: 4.164

8.  Evaluation of Mortality in Atrial Fibrillation: Clinical Outcomes in Digital Electrocardiography (CODE) Study.

Authors:  Gabriela M M Paixão; Luis Gustavo S Silva; Paulo R Gomes; Emilly M Lima; Milton P F Ferreira; Derick M Oliveira; Manoel H Ribeiro; Antonio H Ribeiro; Jamil S Nascimento; Jéssica A Canazart; Leonardo B Ribeiro; Emelia J Benjamin; Peter W Macfarlane; Milena S Marcolino; Antonio L Ribeiro
Journal:  Glob Heart       Date:  2020-07-28
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.